Today w/ partner Otsuka we announced positive topline results from the Ph3 FUSION study evaluating an investigational RNA-targeted medicine for people w/ amyotrophic lateral sclerosis (#ALS) caused by mutations in the fused in sarcoma (FUS) gene: https://t.co/5FKM4BdUns
$IONS
Today w/ partner Otsuka we announced positive topline results from the Ph3 FUSION study evaluating an investigational RNA-targeted medicine for people w/ amyotrophic lateral sclerosis (#ALS) caused by mutations in the fused in sarcoma (FUS) gene: https://t.co/5FKM4BdUns
$IONS
Standing ovations for the โDr Laljiโ award recipient - for the development of #Jacifusen (#ION363), a gene therapy for FUS-ALS - Dr. Neil Shneider!
These are the faces of FUS ALS.
Some of these beautiful heroes have left us, but thanks to their courage, many others still fight!
@CDCEnvironment Why doesnโt the #ALSregistry track ALS in people under the age of 18?
In addition to juvenile ALS #jALS, pediatric ALS #pALS also occurs. Accurate data & representation of this disease matters! Please amend registry to include those under 18 too!
@iamalsorg@alsassociation
@TargetALS_fdn Thank you for bringing awareness to juvenile ALS! Didnโt see this mentioned in your blog post & want folks to be aware there is currently a clinical trial for FUS mutations (the #1 cause of pediatric & juvenile ALS). https://t.co/PnIRPwOUYc
Like always children are the least of this nationโs concern. WHY not add those under 18 to the register?? ITS NO WONDER KIDS ARE BEING MISDIAGNOSED AND NOT COUNTED. ITS NO WONDER NO KNOWS PEDIATRIC/JUVENILE ALS EXISTS
New episode LIVE! This week, Stan interviews Sonja and Dr. Neil Shneider of @ColumbiaPS as they discuss Annaโs story โ a girl fighting a fatal form of ALS.
Stream here: https://t.co/4Y43FKjyJ9
#nlorem#ALS#treatment#columbiaMed#podcast
Via @NatureMedicine: A study by @NeilShneider et al reported that an antisense oligonucleotide reduced a toxic protein in an #ALS patient with the FUS mutation. The promising results have paved the way for a clinical trial with multiple patients. https://t.co/OOBW9hLrUd